MENU
 JPMA
  • Access
  • Japanese
  • About JPMA

    About JPMA Top

    • Top Message
    • Outline of JPMA
    • Policies and Activities
    • Voluntary Standards
    • Vision, Policy Proposals
    • Organization
    • Member Companies
  • About Pharmaceuticals

    About Pharmaceuticals Top

    • General Drug Guide
    • Clinical Trials Information
    • Together with Patients
  • Information from the Committee

    Information from the Committee Top

    • Code Compliance Promotion Committee
    • Industry Policy Committee
    • Distribution Appropriateness Committee
    • Drug Evaluation Committee
    • Quality Committee
    • Biopharmaceutical Committee
    • Regulatory Affairs Committee
    • Intellectual Property Committee
    • Research and Development Committee
    • International Committee
    • Public Relations Committee
    • Patient Organization Collaboration Promotion Committee
    • ICH Project
    • APAC Project
    • Pharmaceutical Counseling and Response Review Committee
    • Environmental Issues Review Committee
  • Newsletter
  • Newsroom

    Newsroom Top

    • News Releases and Notices
    • JPMA Newsletter
    • Updates
    • Publications
    • Events
    • JPMA's video contents and advertisements
  • The Office of Pharmaceutical Industry Research
Close
 JPMA

Return to Site Top

  • For Patients and the Public (About Pharmaceuticals)
    For Patients and the Public (About Pharmaceuticals) Top
    • General Drug Guide
    • Clinical Trials Information
    • Together with Patients
  • Information from the Committee
    Information from the Committee Top
    • Code Compliance Promotion Committee
    • Industry Policy Committee
    • Distribution Appropriateness Committee
    • Drug Evaluation Committee
    • Quality Committee
    • Biopharmaceutical Committee
    • Regulatory Affairs Committee
    • Intellectual Property Committee
    • Research and Development Committee
    • International Committee
    • Public Relations Committee
    • Patient Organization Collaboration Promotion Committee
    • ICH Project
    • APAC Project
    • Pharmaceutical Counseling and Response Review Committee
    • Environmental Issues Review Committee
  • About JPMA
    About JPMA Top
    • Top Message
    • Outline of JPMA
    • Policies and Activities
    • Voluntary Standards
    • Vision, Policy Proposals
    • Organization
    • Member Companies
  • Policies and Activities
    Policies and Activities Top
    • Business Policy, Business Plan, Implementation Plan
    • Committee Activities
    • Convention on Biological Diversity
  • Voluntary Standards
    Voluntary Standards Top
    • Charter of Conduct
    • JPMA Code of Practice
    • Transparency Guidelines for Relationships between Corporate Activities and Medical Institutions
    • Transparency Guidelines for Relationships between Corporate Activities and Patient Groups
    • Guidelines for the Preparation of Product Information Summaries, etc. for Ethical Drugs (Abbreviated name: Preparation Guidelines)
    • Clinical Research
    • Basic Principles and Action Guidelines on Biodiversity
    • Guidelines for Proper Competition at Japan Pharmaceutical Manufacturers Association Meetings
    • Guideline for the Promotion of the Industry Vision 2035
  • Newsroom
    Newsroom Top
    • News Releases and Notices
    • JPMA Newsletter
    • Updates
    • Publications
    • Events
    • JPMA's video contents and advertisements
  • The Office of Pharmaceutical Industry Research Page will open in a new window.
  • Social Media Policy
  • Website Terms of Use
  • Access
  • Japanese
  • Top
  • Voluntary Standards
  • Charter of Conduct

Charter of Conduct

  • JPMA Corporate Code of Conduct

    To help member companies fulfill their mission as pharmaceutical companies, we have established the “JPMA Code of Conduct.”

  • JPMA Compliance Program Guidelines

    To ensure thorough compliance with laws and regulations by officers and employees at each member company, we have established the “JPMA Compliance Program Guidelines.”

Share this page

  • Post
  • Share

TOP

Site Search

  • Top
  • Voluntary Standards
  • Charter of Conduct
  • JPMA PR and Communication Activities
  • Pharmaceutical Research Institute
  • List of Non-Financial Information Disclosure by Member Companies
  • STOP AMR
  • About JPMA
  • Policies and Activities
  • Voluntary Standards
  • Global Health
  • Newsroom
  • For Patients and the Public (About Pharmaceuticals)
  • Clinical Trials Information
  • Information from the Committee
  • JapanesePage will open in a new window.
  •  x
  •  facebook
  •  youtube
  • Site Map
  • Website Terms of Use
  • Basic Policy on Information Security
  • Social Media Policy
  • Links
  • Accessibility Policy
  • PRAISE-NET Login

© Japan Pharmaceutical Manufacturers
Association(JPMA).All rights reserved.

Notification

This website uses automatic translation.
The translated content may not always be fully consistent with the original Japanese content.